
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
06/13/2025 | Q1 | -- | $566.4K | -$0.45 | -- | -- |
12/31/2024 | Q4 | -- | $1M | -$1.84 | -- | -- |
11/27/2024 | Q3 | -- | $1.8M | -$1.78 | -- | -- |
08/14/2024 | Q2 | -- | $1.3M | -$2.73 | -- | -- |
05/17/2024 | Q1 | -- | $968.1K | -$4.93 | -- | -- |
12/31/2023 | Q4 | -- | $2M | -$16.85 | -- | -- |
11/14/2023 | Q3 | -- | $4M | -$4.49 | -- | -- |
06/30/2023 | Q2 | -- | $5.1M | -$7.46 | -- | -- |
03/31/2023 | Q1 | -- | $5.5M | -$5.00 | -- | -- |
12/31/2022 | Q4 | -- | $4.1M | -$5.48 | -- | -- |
09/30/2022 | Q3 | -- | $4.1M | -$3.60 | -- | -- |
06/30/2022 | Q2 | -- | $7.6M | -$2.20 | -- | -- |
03/31/2022 | Q1 | -- | $8.6M | -$1.20 | -- | -- |
12/31/2021 | Q4 | -- | $8.5M | -$6.40 | -- | -- |
11/15/2021 | Q3 | -- | $8.8M | -$8.60 | -- | -- |
08/16/2021 | Q2 | -- | $11.9M | -$3.40 | -- | -- |
05/17/2021 | Q1 | $8M | $9.2M | -$4.60 | $1.00 | -$5.60 |
03/17/2021 | Q4 | $4.3M | $7.4M | -$3.80 | -$1.40 | -$2.40 |
11/19/2020 | Q3 | $3.7M | $576.6K | -$3.40 | $0.80 | -$4.20 |
06/30/2020 | Q2 | $1.5M | $629K | -$3.20 | -$1.60 | -$1.60 |
03/31/2020 | Q1 | $1.5M | $198.8K | -$12.80 | -$4.00 | -$8.80 |
12/31/2019 | Q4 | $300K | $337.3K | -$71.38 | -$16.00 | -$55.38 |
09/30/2019 | Q3 | -- | $184.5K | -$93.20 | -- | -- |
06/30/2019 | Q2 | $2M | $727.9K | -$80.40 | -$68.00 | -$12.40 |
03/31/2019 | Q1 | -- | $1.7M | -$46.00 | -- | -- |
12/31/2018 | Q4 | -- | $2.3M | -$170.80 | -- | -- |
09/30/2018 | Q3 | -- | $2.1M | -$96.00 | -- | -- |
06/30/2018 | Q2 | -- | $2.3M | -$116.00 | -- | -- |
03/31/2018 | Q1 | -- | $1.5M | -$72.00 | -- | -- |
12/31/2017 | Q4 | -- | $2.1M | -$100.79 | -- | -- |
09/30/2017 | Q3 | -- | $1.4M | -$100.00 | -- | -- |
06/30/2017 | Q2 | -- | $1M | -$1,260.00 | -- | -- |
03/31/2017 | Q1 | -- | $604.6K | -$4.21 | -- | -- |
12/31/2016 | Q4 | -- | $552.5K | -$1.55 | -- | -- |
09/30/2016 | Q3 | -- | $315.7K | -$1.11 | -- | -- |
06/30/2016 | Q2 | -- | $828.5K | -$0.32 | -- | -- |
03/31/2016 | Q1 | -- | $227.8K | -$8.00 | -- | -- |
12/31/2015 | Q4 | -- | $245.3K | -$0.01 | -- | -- |
09/30/2015 | Q3 | -- | $289.6K | -$48.00 | -- | -- |
Safe & Green Holdings reported $566.4K worth of top line sales in its most recent quarter.
Safe & Green Holdings announced earnings per share of -$0.45 which represents a miss of analyst forecast a -- per share.
Safe & Green Holdings reported -$323.8K that represents -$0.05 per share over the last quarter.
Safe & Green Holdings's earnings are forecast to grow from -$10.53 per share to -- per share next year representing an increase of --.
Safe & Green Holdings's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.